A review of the off-label use of selamectin (Stronghold/Revolution) in dogs and cats

Maggie Fisher, David Shanks (2008) A review of the off-label use of selamectin (Stronghold/Revolution) in dogs and cats Acta Vet Scand (IF: 1.7) 50(1) 46

Abstract

Since its introduction approximately seven years ago, selamectin (Stronghold/Revolution, Pfizer Inc.) has been used off-label to treat a number of ecto- and endoparasite conditions in dogs and cats. It has been used as a successful prophylactic against Dirofilaria repens and as a treatment for Aelurostrongylus abstrusus in cats. It has also been used to treat notoedric mange, infestation with the nasal mite Pneumonyssoides caninum, Cheyletiella spp. and Neotrombicula autumnalis infestations and larval Cordylobia anthropophaga infection. However, to date attempts to treat generalised canine demodicosis have not been successful. In all cases, treatment was apparently well tolerated by the host.

Links

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612660
http://www.ncbi.nlm.nih.gov/pubmed/19032763
http://dx.doi.org/10.1186/1751-0147-50-46

Similar articles

Tools

Export to RIS